Ambassador Webcams
My Meeting Guide
MEET IN NICE Nice Convention Bureau Official Website
A World First in the Treatment of Breast Cancer in Nice
Add to my meeting guide Log out

A World First in the Treatment of Breast Cancer in Nice

At Nice's Centre Antoine Lacassagne, it is now possible to cure small breast cancers in only a day.

A Reduced Radiation Time

For the first time in the world, a patient with a small-sized breast cancer was treated with a radiotherapy session in the operating theatre during the operation to remove her tumor (Intra-Operatory Radio Therapy - IORT) using the new Papillon+™ equipment in two minutes instead of the 30 minutes previously required. With this innovation, it was possible to treat the patient in a single day, instead of 3 or 4 days in hospital and 6 weeks of radiotherapy. With the new Papillon+™ equipment designed by Dr Jean Pierre GERARD, Radiotherapist at the Centre Antoine Lacassagne, in collaboration with a British start-up (ARIANE cpy), the irradiation time is reduced to 1 to 2 minutes using a novel cooling system.


This New Technique Has Two Major Advantages:

- for the patient, thanks to this out-patient surgery, a lessened feeling of the seriousness of her disease treated in a single day (instead of 3 or 4 days in hospital and 6 weeks of radiation).
- for the hospital, a major time saving (30 minutes), saving surgeon doctor and staff time by enabling better use of the operating theatre.


A Step Towards Better Healing, without Scarring

The first patient to benefit from this new technique was operated on 26 October. When she arrived at the Centre, she was anaesthetised in an operating room with radiation-shielded walls.
The patient returned to her room at noon, completely awake. After a visit by the surgeon and the oncologist-radiotherapist, she was able to return home at 7.00 pm.
Three weeks later, the patient is doing well and the operated breast has returned to its normal appearance.
A second patient was operated on under identical circumstances by Prof. Emmanuel BARRANGER on 16 November.


"We hope for at least 90% cures and less than 4% local relapse. It is likely that in 2019 this technique for patients who are aged 60 or over (after 60 years, the risk of local relapse is lower) will become widely available in France and the world. We are taking a step towards better healing, without mutilation and, especially to less drastic treatments which help overcome the psychological trial that cancerous disease represents," said Dr. Jean Pierre GERARD.

Article published on 21 November 2018